| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |